Faruk Capan
Chief Innovation Officer & Chief Executive Officer, EVERSANA INTOUCH
Expertise:
Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,500 employees globally that joined EVERSANA in December 2021. Faruk leads the Intouch Group team to drive next-generation ideas and strategies for clients across the pharmaceutical industry. He is a graduate of Marmara University and holds a Master of Business Administration from the University of Central Missouri.
Articles by Faruk Capan
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
In the fast-evolving landscape of pharmaceuticals, staying ahead demands more than just adapting to today’s challenges – it requires pioneering the future. Introducing intentional innovation, the sweet spot where blue-sky imagination meets on-the-ground effort. It’s being able to not only ideate, but to actually accomplish the groundbreaking “firsts”. Much of the conversation about innovation focuses on artificial intelligence, but life-science companies need more than AI as a buzzword. They need to know how AI – and other groundbreaking innovations – can realistically be put to work transforming their business. You need more than theoretical answers. You need proof. At EVERSANA, our innovations go beyond just addressing today’s challenges; they are reinventing […]
Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients
Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely difficult to diagnose and treat effectively, advancements toward alleviating the toll they take on patients’ lives are often few and far between. However, the merging of healthcare and advancing technology, specifically Artificial Intelligence (AI) and Machine Learning (ML), has given rise to a new sense of hope and progress in the rare disease community. AI and ML have the ability to analyze extensive amounts of real-world data and uncover previously unknown patterns and insights […]
Missed Connection or Meant to Be?
EVERSANA is raising the questions the industry is thinking but is too afraid to ask aloud: Has omnichannel lived up to its promise of the “right message at the right time” to drive meaningful results that wouldn’t otherwise be realized by traditional sales and marketing strategies? Are those “seamless brand experiences” integrating the right mix of digital tools and one-on-one personal engagements accelerating patients’ time to therapy and delivering business impact? Are more prescriptions being written and fulfilled to validate the time, money and resources allocated? Unfortunately, the conclusion is no. The promise of omnichannel activation has fallen short for many pharma manufacturers due to stifling obstacles, coupled with high […]